NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.40
+0.14 (0.46%)
At close: Jun 12, 2026, 4:00 PM EDT
31.00
+0.60 (1.97%)
After-hours: Jun 12, 2026, 7:38 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $3.55 billion as of June 12, 2026. Its market cap has increased by 79.55% in one year.
Market Cap
3.55B
Enterprise Value
2.85B
1-Year Change
79.55%
Ranking
Category
Stock Price
$30.40
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.55B, an increase of 2,201.00%. That is a compound annual growth rate of 79.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.55B | -10.66% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 4.01B |
| Catalyst Pharmaceuticals | 3.84B |
| Edgewise Therapeutics | 3.75B |
| Crinetics Pharmaceuticals | 3.63B |
| ACADIA Pharmaceuticals | 3.61B |
| Denali Therapeutics | 3.44B |
| Viking Therapeutics | 3.34B |
| Telix Pharmaceuticals | 3.26B |